Paper16624488
Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma.
El Gazzar M and 4 others. Biochim Biophys Acta, 2006. Cited by 65 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma. Papers, record 16624488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16624488
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Benzoquinones | Major topic |
| Down-Regulation | Major topic |
| Inflammation | Major topic |
| Leukotrienes | Major topic |
| Animals | |
| Arachidonate 5-Lipoxygenase | |
| Bronchoalveolar Lavage Fluid | |
| Cytokines | |
| Disease Models, Animal | |
| Female | |
| Hypersensitivity | |
| Lung | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Nigella sativa |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL082662 | NHLBI NIH HHS | United States | R01HL082662 | PubMed and NIH | NIH RePORTER |
| R01 HL095686 | NHLBI NIH HHS | United States | R01HL095686 | PubMed and NIH | NIH RePORTER |
| HL 51241 | NHLBI NIH HHS | United States | PubMed | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41509113 | Effects of Nigella sativa and its constituents on total white blood cells count and airway responsiveness value in ovalbumin-induced asthma models: A preclinical systematic review and meta-analysis. | Avicenna J Phytomed | 2025 | https://conductscience.org/library/papers/41509113 | PubMed |
| 41018933 | Thymoquinone Targeting T Helper 2 Cytokines in Animal Models of Asthma: A Systematic Review. | Tanaffos | 2024 | https://conductscience.org/library/papers/41018933 | PubMed |
| 40839182 | Effects of Nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-analysis. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40839182 | PubMed |
| 39464255 | Inflammation and olfactory loss are associated with at least 139 medical conditions. | Front Mol Neurosci | 2024 | https://conductscience.org/library/papers/39464255 | PubMed |
| 38339101 | Chronic Treatment with Nigella sativa Oil Exerts Antimanic Properties and Reduces Brain Inflammation in Rats. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38339101 | PubMed |
| 37760822 | How to Naturally Support the Immune System in Inflammation-Essential Oils as Immune Boosters. | Biomedicines | 2023 | https://conductscience.org/library/papers/37760822 | PubMed |
| 36393974 | Identification of Molecular Markers Related to Immune Infiltration in Patients with Severe Asthma: A Comprehensive Bioinformatics Analysis Based on the Human Bronchial Epithelial Transcriptome. | Dis Markers | 2022 | https://conductscience.org/library/papers/36393974 | PubMed |
| 35972596 | Black Seed (Nigella sativa): A Favourable Alternative Therapy for Inflammatory and Immune System Disorders. | Inflammopharmacology | 2022 | https://conductscience.org/library/papers/35972596 | PubMed |
| 34110959 | Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. | Pharm Biol | 2021 | https://conductscience.org/library/papers/34110959 | PubMed |
| 33976534 | Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/33976534 | PubMed |
| 33859710 | Thymoquinone Ameliorates Lung Inflammation and Pathological Changes Observed in Lipopolysaccharide-Induced Lung Injury. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/33859710 | PubMed |
| 33047412 | Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. | Phytother Res | 2021 | https://conductscience.org/library/papers/33047412 | PubMed |
| 31143688 | Clinical and experimental effects of Nigella sativa and its constituents on respiratory and allergic disorders. | Avicenna J Phytomed | 2019 | https://conductscience.org/library/papers/31143688 | PubMed |
| 31143211 | Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies. | Tanaffos | 2018 | https://conductscience.org/library/papers/31143211 | PubMed |
| 30166900 | Medicinal benefits of Nigella sativa in bronchial asthma: A literature review. | Saudi Pharm J | 2017 | https://conductscience.org/library/papers/30166900 | PubMed |
| 29629288 | Natural therapeutic approach of Nigella sativa (Black seed) fixed oil in management of Sinusitis. | Integr Med Res | 2018 | https://conductscience.org/library/papers/29629288 | PubMed |
| 27419091 | The effects of Nigella sativa on neural damage after pentylenetetrazole induced seizures in rats. | J Tradit Complement Med | 2016 | https://conductscience.org/library/papers/27419091 | PubMed |
| 25859298 | Thymoquinone: an emerging natural drug with a wide range of medical applications. | Iran J Basic Med Sci | 2014 | https://conductscience.org/library/papers/25859298 | PubMed |
| 25035850 | The effect of single dose of thymoquinone, the main constituents of Nigella sativa, in guinea pig model of asthma. | Bioimpacts | 2014 | https://conductscience.org/library/papers/25035850 | PubMed |
| 23320027 | Intestinal, airway, and cardiovascular relaxant activities of thymoquinone. | Evid Based Complement Alternat Med | 2012 | https://conductscience.org/library/papers/23320027 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALOX5 | 240 | PubTator's text mining | https://conductscience.org/library/genes/240 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16624488
GET https://conductscience.org/api/papers/v1/16624488/cited_by?page=2